Research programme: CFTR channel modulators - Cystic Fibrosis Foundation Therapeutics/EPIX
Alternative Names: CFTR regulators - Cystic Fibrosis Foundation Therapeutics/EPIXLatest Information Update: 16 Oct 2009
At a glance
- Originator Cystic Fibrosis Foundation Therapeutics; EPIX Pharmaceuticals
- Class Small molecules
- Mechanism of Action Cystic fibrosis transmembrane conductance regulator modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cystic fibrosis
Most Recent Events
- 01 Oct 2009 Discontinued - Preclinical for Cystic fibrosis in USA (unspecified route)
- 08 Apr 2008 CFFT increases potential payments to EPIX under new agreement
- 24 Jan 2008 EPIX receives milestone payment from Cystic Fibrosis Foundation Therapeutics for development of CFTR ion channel model